SA
Go ProLog In
APLT
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Hold
10 analysts·Moderate coverage
60
Score
5 Buy (50%)4 Hold (40%)1 Sell (10%)
Rating Breakdown
Strong Buy
00%
Buy
550%
Hold
440%
Sell
110%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$0.25
+142.7%
Consensus
$0.25
+142.7%
Bull
$0.25
+142.7%
12-Month Target Range10 analysts
$0.25$0.25$0.25
Current $0.10Consensus
Current Price
$0.10
Upside to Consensus
$0.15

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

No analyst estimates available

Earnings Surprises

Earnings surprise history unavailable.

Recent Analyst Actions

Dec 12, 2025Robert W. Baird
Baird Downgrades Applied Therapeutics (APLT) to Neutral
Target:$0.25
+109.6%from $0.12
Nov 29, 2024Robert W. Baird
Applied Therapeutics (APLT) PT Lowered to $5 at Baird
Target:$5.00
-46.9%from $9.41
Nov 29, 2024RBC Capital
RBC Capital Downgrades Applied Therapeutics (APLT) to Sector Perform
Target:$4.00
-57.5%from $9.41

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance